Abiraterone and Sitagliptin interaction
Abiraterone and Sitagliptin: the Abiraterone prescribing label describes an interaction that usually calls for monitoring, a dose change, or spacing the doses.
Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.
What the FDA labels say
From the Abiraterone (ABIRATERONE ACETATE) label · effective 2026-06-16
Monitor blood glucose in patients with diabetes and assess if antidiabetic agent dose modifications are required.
Assess if antidiabetic drug dosage needs to be adjusted to minimize the risk of hypoglycemia.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.